What Are We Missing in the Diagnostic Criteria for Migraine?
- 347 Downloads
Purpose of Review
This review is intended to examine how the diagnostic criteria for migraine have evolved over the past 45 years and to evaluate the strengths and weaknesses of the current diagnostic criteria promulgated by the International Classification of Headache Disorders (ICHD).
The ICHD is a comprehensive and systematic classification system for headache disorders. As the pathophysiology of migraine is more fully elucidated and more sophisticated diagnostic technologies are developed (e.g., the identification of biomarkers), the current diagnostic criteria for migraine will likely be further refined. The ICHD has allowed for more precise research study design in the field of headache medicine.
The current diagnostic criteria for migraine outlined in the 3rd version of the ICHD are far more sensitive and specific than the clinical criteria proposed in 1962. In future iterations, dividing episodic and chronic migraine into subtypes based on frequency (i.e., low frequency vs high frequency; near-daily vs daily) potentially could assist in guiding clinical management. In addition, a better understanding of aura, vestibular migraine, migrainous infarction, and hemiplegic migraine likely will lead to more refined diagnostic criteria for those entities.
KeywordsMigraine Aura International Classification of Headache Disorders
Compliance with Ethical Standards
Conflict of Interest
Amanda Tinsley reports that she is a speaker for Amgen’s Speaker Bureau for migraine disease state and CGRP antagonist. John Farr Rothrock declares no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia. 1988;8(suppl 7):1–96.Google Scholar
- 4.•• The International Classification of Headache Disorders. Cephalalgia. 2018;38:1–211 The “Bible” of headache medicine outlining diagnostic criteria for headache disorders. Google Scholar
- 8.• Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28:183–7 A landmark study reporting the substantial elevation of CGRP levels in external jugular venous blood of migraine patients. CrossRefGoogle Scholar
- 16.• Lipton R, Stewart W, Cady R, Hall C, et al. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache. 2000;40:783–91 Randomized cross-over study demonstrating a sumatriptan-responsive mechanism for a variety of headache types experienced by migraineurs. CrossRefGoogle Scholar
- 18.Rothrock J, Patel M, Lyden P, Jackson C. Demographic and clinical characteristics of patients with episodic migraine versus chronic daily headache. Cephalalgia 1996.Google Scholar
- 19.Michael A, Michael D, Rothrock J. Predictors of early positive response to treatment of chronic migraine with on a botulinum toxin A. Headache 2016.Google Scholar